DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

BioMarin Pharmaceutical (NASDAQ: BMRN)

120.28 -2.67 (-2.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMRN $120.28 -2.17%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $122.38
Previous Close $122.95
Daily Range $120.21 - $123.14
52-Week Range $55.36 - $133.54
Market Cap $19.1B
P/E Ratio -133.64
Dividend (Yield) $0.00 (0.0%)
Volume 821,777
Average Daily Volume 1,842,340
Current FY EPS -$2.34




Drug Makers

BioMarin Pharmaceutical (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary Rss Feed

10 Largest Companies by Market Cap in Biotech

The bigger they are, the harder they climb? How the biggest biotechs are booming.

Catalyst Pharma Competitor Surprises With Positive Orphan Disease Drug Study Results

Santhera -- A Duchenne Drug With Positive Study Results That Few Know About

Wedbush: BioMarin Pharma Still Worth $104/Share

4 Big Biopharma Deals We Might See In 2015

J.P. Morgan's 3 Biotechnology Picks

BioMarin Pharmaceutical Larger Than S&P 500 Component Omnicom Group

Why 1 Wall Street Firm Thinks BioMarin Pharmaceutical Inc. Could Soar

One Wall Street analyst offers her opinion on whether BioMarin is a takeover candidate, as well as what a "blue-skies scenario" might entail for shareholders if everything goes their way.

Midcap Growth Funds Power Ahead Amid March Malaise

16 Biotech Catalysts SunTrust Is Tracking

See More BMRN News...

BMRN's Top Competitors

BMRN $120.28 (-2.17%)
Current stock: BMRN
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB